(Q39659986)

English

p21WAF1 Is Involved in Interferon-β- Induced Attenuation of Telomerase Activity and Human Telomerase Reverse Transcriptase (hTERT) Expression in Ovarian Cancer

scientific article published on August 31, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

p21 WAF1 is involved in interferon-β-induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

p21WAF1 Is Involved in Interferon-β- Induced Attenuation of Telomerase Activity and Human Telomerase Reverse Transcriptase (hTERT) Expression in Ovarian Cancer (English)

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

1 reference

based on heuristic

inferred from title

author name string

Ji-Hae Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Seung-Yeul Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Je-Ho Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Seung-Hoon Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20814747

6 July 2024

publication date

31 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s10059-010-0131-y.pdf

Portable Document Format

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

http://link.springer.com/article/10.1007/s10059-010-0131-y/fulltext.html

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

https://api.elsevier.com/content/article/PII:S1016847823111083?httpAccept=text/xml

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

https://api.elsevier.com/content/article/PII:S1016847823111083?httpAccept=text/plain

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

http://link.springer.com/content/pdf/10.1007/s10059-010-0131-y

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Molecules and Cells

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

327-333

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Telomerase regulation during entry into the cell cycle in normal human T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0131-Y

21 January 2018

Rb and E2F-1 regulate telomerase activity in human cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0131-Y

21 January 2018

Type I interferons

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0131-Y

21 January 2018

Effects of olprinone on neuromuscular blockade caused by vecuronium

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0131-Y

21 January 2018

Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0131-Y

21 January 2018

Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells.

1

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

2

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer

4

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Telomerase activity in human ovarian carcinoma

8

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs

10

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death

12

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

WAF1, a potential mediator of p53 tumor suppression

13

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21

14

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Inhibition of telomerase limits the growth of human cancer cells.

15

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis

16

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry

17

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cells

18

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors

19

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Role of apoptotic regulators in human epithelial ovarian cancer

22

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation

24

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors

25

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

26

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression

27

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.

28

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis

29

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha

30

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Overexpression of the oncogene c-erb B2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regression

31

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

32

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells

33

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma.

34

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Telomerase catalytic subunit homologs from fission yeast and human

35

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity

36

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy

37

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites

38

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7

39

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

p53-dependent down-regulation of telomerase is mediated by p21waf1.

40

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

A survey of telomerase activity in human cancer

41

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Detection and clinical correlations of ras gene mutations in human ovarian tumors

44

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Telomerase activity in benign and malignant epithelial ovarian tumors

45

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Myc activates telomerase

46

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells

47

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

50

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells

51

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Cell cycle-dependent modulation of telomerase activity in tumor cells.

52

1 reference

10.1007/S10059-010-0131-Y

https://api.crossref.org/works/10.1007/S10059-010-0131-Y

6 July 2024

Identifiers

10.1007/S10059-010-0131-Y

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39659986&oldid=2203064073"